Se protéger du SIDA ? - L’exemple des singes d’Afrique

Béatrice Jacquelin; Olivier Rescanière; Anne-Sophie Liovat; Gaël Petitjean; Françoise Barré-Sinoussi; Michaela Müller-Trutwin

doi:doi:10.1051/medsci/2010265461

Accès gratuit

Numéro		Med Sci (Paris) Volume 26, Numéro 5, Mai 2010


Page(s)		461 - 463
Section		Nouvelles
DOI		http://dx.doi.org/10.1051/medsci/2010265461
Publié en ligne		15 May 2010

Peeters M, Chaix ML, Delaporte E. Phylogénie des SIV et des VIH. Mieux comprendre l’origine des VIH. Med Sci (Paris) 2008; 24 : 621–8.
Liovat AS, Jacquelin B, Ploquin MJ, et al. African non human primates infected by SIV - why don’t they get sick ? Lessons from studies on the early phase of non-pathogenic SIV infection. Curr HIV Res 2009; 7 : 39–50.
Lozano Reina JM, Favre D, Kasakow Z, et al. Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 2009; 83 : 2770–7.
Sodora DL, Allan JS, Apetrei C, et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009; 15 : 861–5.
Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179 : 859–70.
Kornfeld C, Ploquin MJ, Pandrea I, et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005; 115 : 1082–91.
Stacey AR, Norris PJ, Qin L, et al. Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83 : 3719–33.
Diop OM, Ploquin MJ, Mortara L, et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 2008; 82 : 5145–52.
Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119 : 3544–55.
Bosinger SE, Li Q, Gordon SN, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009; 119 : 3556–72.
Choudhary SK, Vrisekoop N, Jansen CA, et al. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 2007; 81 : 8838–42.
Martinez V, Autran B. Les HIV controllers : une nouvelle entité évolutive de l’infection par le VIH ? Med Sci (Paris) 2008; 24 : 7–9.

[1] Peeters M, Chaix ML, Delaporte E. Phylogénie des SIV et des VIH. Mieux comprendre l’origine des VIH. Med Sci (Paris) 2008; 24 : 621–8.

[2] Liovat AS, Jacquelin B, Ploquin MJ, et al. African non human primates infected by SIV - why don’t they get sick ? Lessons from studies on the early phase of non-pathogenic SIV infection. Curr HIV Res 2009; 7 : 39–50.

[3] Lozano Reina JM, Favre D, Kasakow Z, et al. Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 2009; 83 : 2770–7.

[4] Sodora DL, Allan JS, Apetrei C, et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009; 15 : 861–5.

[5] Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179 : 859–70.

[6] Kornfeld C, Ploquin MJ, Pandrea I, et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005; 115 : 1082–91.

[7] Stacey AR, Norris PJ, Qin L, et al. Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83 : 3719–33.

[8] Diop OM, Ploquin MJ, Mortara L, et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 2008; 82 : 5145–52.

[9] Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119 : 3544–55.

[10] Bosinger SE, Li Q, Gordon SN, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009; 119 : 3556–72.

[11] Choudhary SK, Vrisekoop N, Jansen CA, et al. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 2007; 81 : 8838–42.

[12] Martinez V, Autran B. Les HIV controllers : une nouvelle entité évolutive de l’infection par le VIH ? Med Sci (Paris) 2008; 24 : 7–9.

Prix Nobel 2012